Barclays Upgrades Waters (NYSE:WAT) to “Equal Weight”
Waters (NYSE:WAT – Get Free Report) was upgraded by investment analysts at Barclays from an “underweight” rating to an “equal weight” rating in a research note issued on Monday, MarketBeat Ratings reports. The firm presently has a $415.00 price target on the medical instruments supplier’s stock, up from their prior price target of $360.00. Barclays‘s […]
Waters (NYSE:WAT – Get Free Report) was upgraded by investment analysts at Barclays from an “underweight” rating to an “equal weight” rating in a research note issued on Monday, MarketBeat Ratings reports. The firm presently has a $415.00 price target on the medical instruments supplier’s stock, up from their prior price target of $360.00. Barclays‘s […]
